Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
The American Journal of Gastroenterology
|
July 15, 2024
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease
Hannah K Systrom, Victoria Rai, Siddharth Singh, et al.
Digestive Diseases and Sciences
|
January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology
Gaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
Alimentary Pharmacology & Therapeutics
|
August 15, 2020
Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease
Abhinav Vasudevan, Nina Parthasarathy, Danny Con, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 11, 2010
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all
Gil Y Melmed, Brennan M Spiegel, Brian Bressler, et al.
Alimentary Pharmacology & Therapeutics
|
February 20, 2021
Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates
Emma Flanagan, Emily K Wright, Winita Hardikar, et al.
Inflammatory Bowel Diseases
|
April 9, 2016
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel
Shane M Devlin, Gil Y Melmed, Peter M Irving, et al.
Journal of Gastroenterology and Hepatology
|
October 10, 2025
IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia
Uma Mahadevan, Vipul Jairath, Jakob Begun, et al.
Journal of Crohn'S & Colitis
|
February 18, 2021
Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II
Walter Reinisch, William J Sandborn, Silvio Danese, et al.
Plos One
|
July 29, 2016
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy
Wilhelmina M C Timmermans, Jan A M van Laar, Tim B van der Houwen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 1, 2019
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
Konstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
The American Journal of Gastroenterology
|
July 15, 2024
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease
Hannah K Systrom, Victoria Rai, Siddharth Singh, et al.
Digestive Diseases and Sciences
|
January 10, 2022
Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology
Gaurav Syal, Miles P Sparrow, Fernando Velayos, et al.
Alimentary Pharmacology & Therapeutics
|
August 15, 2020
Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease
Abhinav Vasudevan, Nina Parthasarathy, Danny Con, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 11, 2010
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all
Gil Y Melmed, Brennan M Spiegel, Brian Bressler, et al.
Alimentary Pharmacology & Therapeutics
|
February 20, 2021
Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates
Emma Flanagan, Emily K Wright, Winita Hardikar, et al.
Inflammatory Bowel Diseases
|
April 9, 2016
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel
Shane M Devlin, Gil Y Melmed, Peter M Irving, et al.
Journal of Gastroenterology and Hepatology
|
October 10, 2025
IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia
Uma Mahadevan, Vipul Jairath, Jakob Begun, et al.
Journal of Crohn'S & Colitis
|
February 18, 2021
Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II
Walter Reinisch, William J Sandborn, Silvio Danese, et al.
Plos One
|
July 29, 2016
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy
Wilhelmina M C Timmermans, Jan A M van Laar, Tim B van der Houwen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 1, 2019
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
Konstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, et al.
Page
of 10